Literature DB >> 21311503

Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation.

J L Slaughter1, T Pakrashi, D E Jones, A P South, T A Shah.   

Abstract

OBJECTIVE: The goal of this study was to delineate the epidemiology of echocardiographically diagnosed pulmonary hypertension (PH) in extremely low birth weight (ELBW) infants with bronchopulmonary dysplasia (BPD) requiring prolonged positive pressure ventilation (PPV), and to determine the independent relationship between PH and mortality in these patients. STUDY
DESIGN: Our retrospective cohort included ELBW infants, with BPD requiring prolonged PPV, hospitalized in Cincinnati, Ohio during 2003-2009, as recorded in the National Institute of Child Health and Human Development Neonatal Research Network Database. Following chart review, a logistic regression model was constructed to understand the contribution of PH to mortality in infants with BPD requiring prolonged PPV. RESULT: We identified 216 patients (19%) with BPD requiring prolonged PPV among 1156 ELBW infants. Of these patients, 41% received echocardiography after 4 weeks of life, with 37% showing evidence of PH. Logistic regression analysis demonstrated that infants with BPD requiring prolonged PPV, with PH detectable by echocardiogram, were four times more likely to die (adjusted odds ratio): 4.6, 95% confidence interval: 1.3-16.5) when compared with infants with BPD requiring prolonged PPV without echocardiographic evidence of PH.
CONCLUSION: Pulmonary hypertension appears to be an important, independent determinant of death in infants with BPD requiring prolonged PPV.

Entities:  

Mesh:

Year:  2011        PMID: 21311503     DOI: 10.1038/jp.2010.213

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  75 in total

1.  Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia.

Authors:  Karen K Mestan; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

Review 2.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

3.  Increased Cardiac Output and Preserved Gas Exchange Despite Decreased Alveolar Surface Area in Rats Exposed to Neonatal Hyperoxia and Adult Hypoxia.

Authors:  Kara N Goss; Robert S Tepper; Tim Lahm; Shawn K Ahlfeld
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

4.  Sildenafil Use in Children with Pulmonary Hypertension.

Authors:  Jennifer L Cohen; Shannon N Nees; Gerson A Valencia; Erika B Rosenzweig; Usha S Krishnan
Journal:  J Pediatr       Date:  2018-11-02       Impact factor: 4.406

5.  Prospective analysis of pulmonary hypertension in extremely low birth weight infants.

Authors:  Ramachandra Bhat; Ariel A Salas; Chris Foster; Waldemar A Carlo; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2012-02-06       Impact factor: 7.124

6.  Increased susceptibility to hyperoxic lung injury and alveolar simplification in newborn rats by prenatal administration of benzo[a]pyrene.

Authors:  Vijay S Thakur; Yanhong W Liang; Krithika Lingappan; Weiwu Jiang; Lihua Wang; Roberto Barrios; Guodong Zhou; Bharath Guntupalli; Binoy Shivanna; Paramahamsa Maturu; Stephen E Welty; Bhagavatula Moorthy; Xanthi I Couroucli
Journal:  Toxicol Lett       Date:  2014-03-19       Impact factor: 4.372

7.  Mortality among infants with evolving bronchopulmonary dysplasia increases with major surgery and with pulmonary hypertension.

Authors:  L B DeVries; R J Heyne; C Ramaciotti; L S Brown; M A Jaleel; V S Kapadia; P J Burchfield; L P Brion
Journal:  J Perinatol       Date:  2017-06-15       Impact factor: 2.521

Review 8.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

Review 9.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Sara K Berkelhamer; Karen K Mestan; Robin H Steinhorn
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Pulmonary hypertension in extremely low birth weight infants: characteristics and outcomes.

Authors:  Wambui Waruingi; Maroun Jean Mhanna
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.